Principal U.S. Large-Cap Multi-Factor ETF (PLC)

NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Marex Group PLC ("Marex" or the "Company") (NASDAQ: MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Marex Group PLC (“Marex” or the “Company”) (NASDAQ: MRX).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.

LONDON, UK / ACCESS Newswire / August 19, 2025 / Guardian Metal Resources plc (LON:GMET)(OTCQX:GMTLF), a strategic tungsten development Company focused in Nevada, USA, notes today's announcement by Power Metal Resources plc ("Power Metal") regarding the agreement to sell its remaining 24,699,825 ordinary shares in Guardian Metal ("Sale Shares") for £13,584,904 representing a price of 55p per Sale Share to an investment fund managed by Duquesne Family Office LLC ("Duquesne"). Following the disposal, the new shareholder will hold a 14.75% interest in the issued share capital of the Company.

Genflow Advances World's First Longevity Gene Therapy Trial in Dogs with No Adverse Effects Reported LONDON, UK / ACCESS Newswire / August 18, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, provides an update on its Dog Aging (GF-1004) study, a proof-of-concept clinical trial evaluating the safety and efficacy of its proprietary SIRT6-centenarian gene therapy for age-related decline in elderly dogs. The randomized, controlled trial, conducted with CRO Syngene, involves 28 beagles aged 10+ years.

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company") Third Patient Treated with HG-CT-1 CAR-T Therapy and Completion of First Adult Dose Cohort LONDON, UNITED KINGDOM / ACCESS Newswire / August 15, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that the third patient has been successfully treated as part of the Company's ongoing Phase I clinical trial of HG-CT-1, its proprietary CAR-T cell therapy for relapsed or refractory acute myeloid leukemia ("R/R AML") in adults. Treatment of this patient, the final participant in the first adult dose cohort, was made possible after the Company secured special permission from the U.S. Food and Drug Administration (FDA) to proceed under exceptional circumstances.

LONDON, UK / ACCESS Newswire / August 13, 2025 / Guardian Metal Resources plc (LON:GMET)(OTCQB:GMTLF), a strategic development and mineral exploration company focused on tungsten in Nevada, USA, is pleased to provide an update for the Pilot North Tungsten Project ("Pilot North" or the "Project"), located in the Walker Lane Mineral Belt, approximately 15km northwest of the Company's Pilot Mountain Project in Nevada. Following the acquisition by direct claim staking of Pilot North, announced on 7 July 2025, an additional 42 Bureau of Land Management ("BLM") Lode Claims have now been staked, significantly expanding the overall footprint of the Project and bringing the total number of BLM mining claims to 101, covering an area of ~2,086 acres.1 The claim staking was in response to highly encouraging rock sample assay results from a 22 sample reconnaissance programme.

Hikma Pharmaceuticals PLC (OTCPK:HKMPF) Q2 2025 Pre Recorded Earnings Conference Call August 7, 2025 2:00 AM ET Company Participants Khalid Waleed Hosny Al Nabilsi - Chief Financial Officer Riad Ali Mishlawi - CEO & Director Riad Ali Mishlawi Thank you, everyone, for joining our 2025 half year results presentation. I'm Riad Mishlawi, CEO of Hikma, and I am joined here by Khalid Nabilsi, our CFO.

Hikma Pharmaceuticals PLC (OTCPK:HKMPF) Q2 2025 Q&A Earnings Call August 7, 2025 4:00 AM ET Company Participants Khalid Waleed Hosny Al Nabilsi - Chief Financial Officer Riad Ali Mishlawi - CEO & Director Conference Call Participants Beatrice Rose Fairbairn - Joh. Berenberg, Gossler & Co. KG, Research Division James Daniel Gordon - JPMorgan Chase & Co, Research Division Kane Slutzkin - Deutsche Bank AG, Research Division Sebastien Guillaume-Bernard Jantet - Panmure Liberum Limited, Research Division Sidhartha Modi - Barclays Bank PLC, Research Division Victor Floch - BNP Paribas Exane, Research Division Xue Chen - Barclays Bank PLC, Research Division Operator Welcome to Hikma's 2025 Interim Results meeting with our CEO, Riad Mishlawi; and CFO of Khalid Nabilsi.

Desert Scheelite: Further High-Grade Tungsten, Copper, Silver & Zinc LONDON, UK / ACCESS Newswire / August 6, 2025 / Guardian Metal Resources plc (LON:GMET)(OTCQX:GMTLF), a strategic mineral exploration and development company focused in Nevada, USA, is pleased to announce further drillhole assay results from the Company's ongoing drilling campaign at its 100% owned Pilot Mountain tungsten Project ("Pilot Mountain" or the "Project") located in Nevada, USA. Laboratory assay results from drill core samples have been received from the final batch of drillholes at the Desert Scheelite zone covering PM25-41 to PM25-052 (Figure 1, Table 1) with results confirming further significant high-grade tungsten mineralisation over significant widths (Table 2).

Approximately $380 million in new contract awards since April fleet status report, backlog stands at $6.9 billion. $0.50 per share cash dividend declared for Q3, eclipsing $1.1 billion in total capital returned to shareholders since Q4 2022.

Vancouver, British Columbia--(Newsfile Corp. - August 5, 2025) - Homerun Resources Inc. (TSXV: HMR) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to announce that the Company's European subsidiary, Homerun Energy has entered into a collaboration agreement with Igraine PLC, an investing company focused on alternative energy and life sciences, to work jointly on the deployment of commercial alternative energy solutions in the United Kingdom. Under the terms of the agreement, Igraine and Homerun will work together on the development of pilot projects focused on electric vehicle (EV) charging infrastructure integrated with battery energy storage systems (BESS).

DIVERSIFIED ENERGY COMPANY PLC ("Diversified", or the "Company") DIVERSIFIED ENERGY COMPANY PLC (LSE:DEC, NYSE:DEC) announces that, in accordance with the terms of its share buyback programme announced on 20 March 2025, the Company has purchased 306 Ordinary Shares of 20 Pence each in the capital of the Company (the "Shares") in the market at a volume-weighted average price of $14.3500 per Share through Mizuho Securities USA LLC (MSUSA). The Shares acquired will, in due course, be cancelled.

DIVERSIFIED ENERGY COMPANY PLC ("Diversified", or the "Company") DIVERSIFIED ENERGY COMPANY PLC (LSE:DEC, NYSE:DEC) announces that, in accordance with the terms of its share buyback programme announced on 20 March 2025, the Company has purchased 53,431 Ordinary Shares of 20 Pence each in the capital of the Company (the "Shares") in the market at a volume-weighted average price of $14.3477 per Share through Mizuho Securities USA LLC (MSUSA). The Shares acquired will, in due course, be cancelled.

Geochemical Results Confirm Significant Cu-Mo Footprint LONDON, UK / ACCESS Newswire / August 1, 2025 / Guardian Metal Resources plc (LON:GMET)(OTCQX:GMTLF), a strategic mineral exploration and development company focused in Nevada, USA, is pleased to announce rock chip assay results and geological observations from the Company's ongoing porphyry copper exploration campaign at its 100% owned Pilot Mountain Project ("Pilot Mountain" or the "Project") located in Nevada, USA. While the Company remains primarily focused on advancing tungsten exploration and development at its co-flagship projects, both are considered to hold significant porphyry copper (Cu) and molybdenum (Mo) potential, which will be further evaluated through targeted drilling at the appropriate stage.

NEW ORLEANS, La., July 31, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 4, 2025 to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY), if they purchased the Company's American Depositary Shares (“ADSs”) between January 13, 2021 and July 28, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

Investors can contact the law firm at no cost to learn more about recovering their losses